COMMUNIQUÉS West-GlobeNewswire

Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion
29/07/2025
LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) -- Altanine, Inc., a pharmaceutical company advancing proprietary drug delivery technologies across high-growth therapeutic areas, today announced the appointment of Charles J [...]
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients
29/07/2025
BERWYN, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, highlights the value of its HUB partnership with Abeona [...]
Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
29/07/2025
The Procedure Utilized Monogram’s mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World’s First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient AUSTIN, Texas, [...]
BioPorto A/S to host an investor webcast on the results for the first half of 2025
29/07/2025
July 29, 2025 News release BioPorto A/S to host an investor webcast on the results for the first half of 2025 COPENHAGEN, DENMARK, July 29, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), [...]
Akari Therapeutics Releases Virtual Investor “What This Means” Segment
29/07/2025
Abizer Gaslightwala, President and CEO of Akari Therapeutics discussed Akari’s commitment to continued research to better understand the multiple effects of its novel spliceosome modulator, PH1 Watch the “What This [...]
Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
29/07/2025
Investors choose to redeem or convert the majority of Series C and Series D Preferred 99% of outstanding preferred series C shares are redeemed or converted and preferred series D reduced 68.5% in outstanding shares BNB [...]
LogicMark, Inc. to Announce Second Quarter 2025 Financial Results on August 12, 2025
29/07/2025
LOUISVILLE, Ky., July 29, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, [...]
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
29/07/2025
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing of a public offering of an aggregate of 2,000,000 shares of its common stock (or pre- [...]
NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion
29/07/2025
The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S. expansion, where over [...]
Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership
29/07/2025
SEATTLE, July 29, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( OTC: FITY ), a pioneer in AI-powered health and wellness solutions, successfully hosted its virtual shareholder teleconference on Monday, July [...]

Pages